Gas exchange abnormalities in Long COVID are driven by the alteration of the vascular component, 2024, Imeri et al.

Discussion in 'Long Covid research' started by SNT Gatchaman, Apr 7, 2024.

  1. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,593
    Location:
    Aotearoa New Zealand
    Gas exchange abnormalities in Long COVID are driven by the alteration of the vascular component
    Gianluca Imeri; Caterina Conti; Anna Caroli; Alberto Arrigoni ; Pietro Bonaffini; Sandro Sironi; Luca Novelli; Federico Raimondi; Greta Chiodini; Simone Vargiu; Fabiano Di Marco

    BACKGROUND
    There are uncertainties whether the impairment of lung diffusing capacity in COVID-19 is due to an alteration in the diffusive conductance of the alveolar membrane (Dm), or an alteration of the alveolar capillary volume (Vc), or a combination of both. The combined measurement DLNO and DLCO diffusion, owing to NO higher affinity and faster reaction rate with haemoglobin compared to CO, enables the simultaneous and rapid determination of both Vc and Dm. The aim of the present study was to better identify the precise cause of post-COVID-19 diffusion impairment.

    METHODS
    Using the combined NO and CO gas transfer techniques (DLNO and DLCO), it is possible to better understand whether gas exchange abnormalities are due to membrane or alveolar capillary volume components. The present study was aimed at evaluating pulmonary gas exchange one year after severe COVID-19.

    RESULTS
    The cohort included 33 survivors to severe COVID-19 (median age 67 years, 70% male) with no pre-existing lung disease, who underwent clinical, lung function and imaging assessments at 12 months due to persistence of respiratory symptoms or radiological impairment. The gas exchange abnormalities were mainly determined by the compromise of the vascular component as demonstrated by vascular pattern of gas exchange impairment (i.e., DLNO/DLCO≥110%, 76% of the sample), and by a reduction of the Vc (73%), while the Dm was reduced only in 9% of the entire sample. We did not find a correlation between the gas exchange impairment and the extent of the chest CT alterations (DLCO p = 0.059 and DLNO p = 0.054), which on average were found to be mild (11% of the parenchyma).

    CONCLUSIONS
    In COVID-19 survivors who are still symptomatic or have minimal CT findings at one year, gas exchange abnormalities are determined by impairment of the vascular component, rather than the diffusive component of the alveolar membrane.

    Link | PDF (Multidisciplinary Respiratory Medicine) [Open Access]
     
    Lilas, RedFox, ukxmrv and 5 others like this.
  2. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,593
    Location:
    Aotearoa New Zealand
    Hospitalised cohort without pre-existing pulmonary disease 12 months on from severe infection but little abnormality on chest CT.
     
    alktipping, RedFox, ukxmrv and 3 others like this.
  3. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,593
    Location:
    Aotearoa New Zealand
     
    Lilas and Hutan like this.
  4. SNT Gatchaman

    SNT Gatchaman Senior Member (Voting Rights)

    Messages:
    4,593
    Location:
    Aotearoa New Zealand
     

Share This Page